3 Penny Stocks That Investors Are Buying in May 2022

With May proving to be another interesting month for penny stocks and blue chips, there is a lot that investors need to keep track of. First and foremost, we know that penny stocks are in an extremely volatile place right now. This is the result of factors such as rising inflation, climbing interest rates, and geopolitical tensions abroad. 

[Read More] Hot Penny Stocks to Buy This Week? 3 to Watch in Late May 2022

All of this has resulted in major losses across the past few months. And while trading on May 17th was the first positive day in quite some time, it is likely that we will continue to see major market fluctuations in the near future. So, to take advantage of this, investors need to have two things: an understanding of how to trade penny stocks, and guidance on what events to take advantage of. Understanding how to trade may seem obvious, but it is a step that is often overlooked by traders. 

And on the other side, knowing what events are going on and how to take advantage of them, is a key aspect to making money with small caps. In addition, traders should know to never buy and sell penny stocks with emotion. This is the easiest way to lose money, and it is almost a guarantee. So, with all of this in mind, let’s take a look at three penny stocks to add to your watchlist right now. 

3 Penny Stocks to Add to Your Watchlist 

  1. Vinco Ventures Inc. (NASDAQ: BBIG
  2. ENDRA Life Sciences Inc. (NASDAQ: NDRA
  3. Ardelyx Inc. (NASDAQ: ARDX

Vinco Ventures Inc. (NASDAQ: BBIG) 

One of the bigger gainers of the day on May 17th is BBIG stock. At EOD, shares of BBIG had shot up by over 5% and more than 4.9% during after hours. This substantial gain adds to BBIG’s one month uptick of over 13%.

In that time, we’ve covered BBIG stock on numerous occasions. And to understand why, we have to take a closer look at the company. The main reason behind its recent move comes as the company set a record and distribution date for the planned business separation of it and Cryptyde. On May 18th, those who hold shares in Vinco, will earn one Cryptyde share for every ten BBIG shares held. 

[Read More] Penny Stocks To Buy Now? 3 To Watch Under $1 This Week

Following this, Cryptyde will trade on the NASDAQ Capital Market under the symbol, ‘TYDE’. If you’re not familiar with Vinco Ventures, it invests in a range of burgeoning media and content technologies. This includes its investment in Cryptyde, but also Lomotif, and others as well.

While Vinco Ventures has shown a sizable amount of bullish sentiment recently, the majority of its trading patterns in the past few months have been extremely volatile. So, keep this in mind if you’re wondering whether or not BBIG belongs on your penny stocks watchlist


ENDRA Life Sciences Inc. (NASDAQ: NDRA) 

Another sizable after-hours gainer today is NDRA stock, which shot up by over 16% after market close. This comes a few days after it reported its Q1 2022 financial data alongside a business update. In the report, the company announced that it was able to raise $8.7 million in gross proceeds from the sale of common stock. 

“We significantly strengthened our balance sheet during the challenging macro environment with the use of our ATM facility to ensure we are well-capitalized to fund the ramp-up in our sales and marketing activities in Europe and our regulatory process in the U.S. Central to these goals, we are advancing our clinical research sites to generate data to support the commercialization of our TAEUS system and the submission of our De Novo request.” 

The CEO and Chairman of ENDRA, Francois Michelon,

This is all very exciting news for the company and shows that it is working hard to grow. While NDRA is volatile, it could be worth adding to your list of penny stocks to watch. 


Ardelyx Inc. (NASDAQ: ARDX) 

During trading and after hours on May 17th, shares of ARDX stock shot up by over 7.4% and more than 4.7% respectively. These sizable gains reflect both the bullishness on the biotech industry and ARDX as well. The most recent news from the company came on May 17th when it announced that it will present additional data that supports the efficacy of its IBSRELA compound. This will be presented at the 2022 Digestive Disease Week Conference from May 21-24 in San Diego, CA. 

If you’re not familiar, Ardelyx is a biotech penny stock that is working on commercializing IBSRELA in the U.S. This compound is already approved in the U.S., and is used in treating a wide variety of ailments. While it is tough to say what the long term trajectory of ARDX stock is, it is clear that investors are interested in the company right now. Considering this, do you think it deserves a spot on your buy list this month or not?


Are Penny Stocks Worth Buying Right Now?

Finding penny stocks that are worth buying in 2022 can be tricky. But, with a clear view of what is going on in the stock market and how to take advantage, it can be much easier than previously imagined. If we consider that there are plenty of factors that could lead to movement, we begin to see ways that investing in penny stocks could be profitable. 

[Read More] What Is A Penny Stock – Definition & More

But, making money with small caps is all about having a well-thought-out strategy and a game plan. So, make sure to keep this in mind and never trade with emotion. With that considered, do you think penny stocks are worth buying right now or not?

[reblex id='29520']

Sign up for our FREE Newsletter and get:

  • The Beginner’s Handbook For Trading Penny Stocks
  • Penny Stock Alerts And Ideas
  • Learn To Trade Penny Stocks
  • Free Access to The Fastest Growing Highest Rated Trading Chatroom
Privacy Policy

Midam Ventures, LLC | (305) 306-3854 | 1501 Venera Ave, Coral Gables, FL 33146 | news@pennystocks.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Best Penny Stocks To Buy Now? 4 To Watch Before Labor Day

Penny stocks to buy or should you avoid them entirely?

Algernon Announces Positive Feedback from Health Canada for Ifenprodil COVID-19 Phase 2 Human Trial

VANCOUVER, British Columbia, April 08, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.…